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Abstract
In Borrelia burgdorferi (Bb), the Lyme disease spirochete, the alternative s factor s
54 (RpoN) directly activates transcription of
another alternative s factor, s
S (RpoS) which, in turn, controls the expression of virulence-associated membrane
lipoproteins. As is customary in s
54-dependent gene control, a putative NtrC-like enhancer-binding protein, Rrp2, is
required to activate the RpoN-RpoS pathway. However, recently it was found that rpoS transcription in Bb also requires
another regulator, BosR, which was previously designated as a Fur or PerR homolog. Given this unexpected requirement for
a second activator to promote s
54-dependent gene transcription, and the fact that regulatory mechanisms among similar
species of pathogenic bacteria can be strain-specific, we sought to confirm the regulatory role of BosR in a second virulent
strain (strain 297) of Bb. Indeed, BosR displayed the same influence over lipoprotein expression and mammalian infectivity
for strain Bb 297 that were previously noted for Bb strain B31. We subsequently found that recombinant BosR (rBosR) bound
to the rpoS gene at three distinct sites, and that binding occurred despite the absence of consensus Fur or Per boxes. This
led to the identification of a novel direct repeat sequence (TAAATTAAAT) critical for rBosR binding in vitro. Mutations in the
repeat sequence markedly inhibited or abolished rBosR binding. Taken together, our studies provide new mechanistic
insights into how BosR likely acts directly on rpoS as a positive transcriptional activator. Additional novelty is engendered by
the facts that, although BosR is a Fur or PerR homolog and it contains zinc (like Fur and PerR), it has other unique features
that clearly set it apart from these other regulators. Our findings also have broader implications regarding a previously
unappreciated layer of control that can be involved in s
54–dependent gene regulation in bacteria.
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Introduction
Bacterial gene expression is primarily controlled at the transcrip-
tional level, which requires a central DNA-dependent RNA
polymerase (RNAP) consisting of catalytic core (a2bb’v; E) and a
dissociable s factor [1]. Gene transcription occurs when the Es-
promoter closed complex (CC) is converted to the open complex
(OC). Among various s factors, the alternative s factor s
54(s
N,
RpoN) is employedbymany bacteriatotranscribegenesinvolved in
a wide variety of cellular functions such as virulence, nitrogen
metabolism, and stress responses [1]. Unlike other s factors, the
Es
54 holoenzyme alone cannot melt the promoter. The Es
54-CC
(held by the interaction of Es
54 with the unique -24/-12 promoter)
remains in this conformation until the activator ATPase interacts
with RNAP, which hydrolyzes ATP for promoter melting [2–4].
The activator ATPase, also known as the enhancer-binding protein
(EBP), usually binds to an enhancer site located ,100–150 bp
upstream of the promoter. Typically, the EBP interacts with the
RNAP via a DNA loopingmechanismthat is modulated by a DNA-
bending protein such as integration host factor (IHF).
Borrelia burgdorferi (Bb), the Lyme disease spirochete [5–6],
encodes three s factors: the housekeeping s
70 (RpoD, BB0712),
and two alternative s factors, s
54 (RpoN, BB0450) and s
S (RpoS,
BB0771) [7]. Abundant evidence [8–11] has revealed that Bb
RpoN directly binds to the -24/-12 site in rpoS promoter and thus
activates rpoS which, in turn, modulates the differential expression
of more than 100 genes involved in Bb virulence, stress adaptation,
and many other functions. Studies have indicated that the Bb
RpoS regulon is triggered by various environmental stimuli
including temperature, pH, cell density, and unknown mammalian
host factors [12–15]. The RpoN-RpoS pathway (or the Rrp2-
RpoN-RpoS pathway) [8–11,16–18] plays a central role in
modulating the differential expression of Bb outer surface
lipoproteins such as outer surface protein C (OspC) [14,19–20]
and decorin-binding protein A (DbpA) [21–23], which are critical
for Bb to transmit from the arthropod tick vector to mammalian
hosts and to maintain its natural life cycle. Activation of the RpoN-
dependent rpoS gene requires the activation of Rrp2 (BB0763), a
putative EBP [17]. Although Rrp2 was presumed to be the sole
NtrC-like EBP in Bb, Rrp2 seems to be unconventional as an EBP
in that it apparently does not bind specifically to the RpoN-
dependent promoter of rpoS [8,24]. The efficient translation of rpoS
mRNA also requires the small RNA DsrA and an atypical RNA
chaperone Hfq [25–26].
Emanating from our general interest in virulence expression in
the Lyme disease spirochete, we previously showed that a
PLoS Pathogens | www.plospathogens.org 1 February 2011 | Volume 7 | Issue 2 | e1001272manganese transporter, BB0219 (BmtA), is required for full
virulence by Bb [27]. The implication that metal transport, and
perhaps metal control over borrelial gene regulation, could
influence Bb’s virulence prompted us to expand our study to
examine other molecules of Bb implicated in metal-sensing. To
this end, BosR (BB0647) is a ferric uptake regulator (Fur)-like
homologue in Bb [7,28] that has been postulated to contribute to
the regulation of oxidative stress responses [29]. In many bacteria,
Fur globally regulates iron homeostasis and other functions [30].
Given the provocative finding that Bb seems not to accumulate
iron [31], it remained tenuous as to whether BosR is involved in
iron uptake by Bb. Nonetheless, BosR may influence cellular
functions other than iron acquisition. Recently, we and others
surprisingly found that expression of the RpoS regulon was
significantly impaired in a mutant deficient in bosR, leading to the
additional unexpected finding that BosR somehow functions as a
second activator to promote s
54-dependent rpoS transcription, and
that such control by BosR ultimately governs the expression of
virulence-associated membrane lipoproteins and mammalian
infectivity by Bb [32–35]. Although this discovery has represented
a major advance in further understanding the regulatory control of
virulence expression by the Lyme disease spirochete, the
observation has engendered many new unanswered questions.
Among them include whether BosR is indeed a global regulator
common to more than the one virulent strain of Bb (examined in
previous studies) [32–34], and how BosR may act mechanistically
to exert its positive control over the RpoN-RpoS regulatory
pathway in Bb. In this report, we provide further evidence for the
direct involvement of BosR in the activation of rpoS, and thus the
RpoS regulon, in a second virulent strain of Bb. We also present
evidence that BosR functions as a DNA-binding protein, but it has
many features that markedly distinguish it from either of its Fur or
PerR homologs. Defining this novel involvement of BosR relative
to its control over the RpoN-RpoS pathway is important for
elucidating Bb’s host adaptation and pathogenesis, and could lead
to innovative strategies for thwarting Lyme disease. This study also
expands our understanding of bacterial sigma factor regulatory
networks, and establishes a new paradigm of an additional
transcriptional activator that is absolutely required for s
54–
dependent gene regulation in a bacterial pathogen.
Results
Inactivation of bosR in Bb strain 297
Previously, we [34] and others [32] found that the mutation of
bosR in Bb strain B31 abolished RpoS, OspC and DbpA
expression. However, there are some notable discrepancies
between these two studies. Hyde et al. [32] found that the mutant
exhibited defects in growth in vitro and in the expression of NapA
(or Dps, implicated in protecting DNA from damage during
starvation or oxidative stress), whereas we [34] showed that the
bosR mutant had normal growth and NapA expression compar-
able to WT Bb. It is also well-documented that transcriptional
regulators and gene control mechanisms can differ widely among
bacterial pathogens of the same species [36–38], and variations in
strain-specific genetic contents, gene expression profiling, and
pathogenicity have been observed, in particular, for different
strains of Bb [39–40]. Thus, to more broadly investigate the role of
BosR in Bb pathogenesis and gene regulation, we generated bosR
mutants in another virulent WT Bb strain (strain 297) via
homologous recombination. As in strain B31 [34], bosR in strain
297 was predicted to be cotranscribed and form an operon with
bb0646 and bb0648 (Fig. S1A). To verify this, RT-PCR using
specific primers and Bb cDNA was performed. As shown in Fig.
S1B, amplicons spanning the junction of bb0646/bosR (lane 3),
bosR/bb0648 (lane 5), or bb0646- bb0648 (lane 6) were generated,
indicating the operonic nature of bb0646, bosR, and bb0648.O f
note, the sequences of this operon and its flanking genes (bb0645
and bb0649) are identical between both strains 297 and B31 (data
not shown). Thus, the same strategies used in the creation of the
bosR mutant in B31 [34] were employed to inactivate bosR in Bb
297. When the suicide vector pOY24 was transformed into Bb
297, two kanamycin-resistant bosR mutant clones (OY08/A11 and
OY08/F4) were obtained. To cis-complement the bosR mutation,
the suicide plasmid pOY83 [34] containing the bb0649-bb0648-
bosR-PflgB-aadA cassette was introduced into the bosR mutants. As a
result, two streptomycin-resistant clones (OY33/A6 and OY33/
F7) were isolated. The inactivation and complementation of bosR
in these strains were confirmed using PCR (Fig. S1C). Moreover,
RT-PCR and immunoblot analyses revealed that BosR expression
was detected in both WT and the complemented strains, but not in
the mutants (Fig. S1D and E).
To ensure that all mutants and complements retained the
plasmids cp26, lp25 and lp28-1 that are essential for Bb virulence
[41–42], PCR-based plasmid profiling was performed. As shown
in Fig. S2A, the WT and bosR mutant OY08/A11 contained the
same plasmid profiles. In addition, OY08/F4 and the comple-
mented strains (OY33/A6 and OY33/F7) contained the same
plasmid profiles as that of the WT strain (data not shown). The
bosR mutant exhibited spirochetal morphology and movement
identical to that of WT under dark-field microscopy. No
discernable growth defect was observed when bosR was inactivat-
ed, and the mutants displayed similar growth patterns to that of
WT (Fig. S2B).
BosR is essential for Bb to establish mammalian infection
The role of BosR in Bb strain 297 mammalian infectivity was
assessed using the murine needle-challenge model of Lyme
borreliosis [43–44]. All mice inoculated with WT or the
complemented strains at a 10
4 inoculum became infected, and
motile spirochetes were isolated from all tissues from these mice
(Table 1). In contrast, the bosR mutants were not recovered from
any mice inoculated with either 10
4 or 10
7 bacteria. These data
establish that previous findings implicating BosR in Bb’s infectivity
and virulence [32,34] were not unique to strain B31, and thus
BosR appears to be essential for conferring virulence to other
pathogenic strains of Bb.
BosR controls the expression of rpoS, ospC and dbpA
To determine whether the loss of Bb strain 297 virulence in the
bosR mutant correlated with a loss in the expression of rpoS, ospC,
Author Summary
Lyme disease, caused by the bacterium Borrelia burgdorferi
(Bb), remains the most common arthropod-borne illness in
the United States. A critical strategy for Bb to maintain its
presence in nature is adaptation to its diverse tick and
mammalian (mouse) hosts. To accomplish this, Bb encodes
a potential gene regulator, BB0647 (BosR). Herein, we
confirmed that BosR is essential for Bb to establish
mammalian infection. We then found that purified
recombinant BosR bound to the promoter DNA (regulatory
region) of rpoS, suggesting that BosR directly controls the
expression of the rpoS gene. This study has revealed a new
mechanism of bacterial gene control. The discovery that
BosR governs Bb’s virulence may lead to new strategies to
interrupt the bacterium’s complex life cycle.
Borrelia burgdorferi BosR
PLoS Pathogens | www.plospathogens.org 2 February 2011 | Volume 7 | Issue 2 | e1001272and dbpA, as has been noted for strain B31 [32,34], we further
assessed the effect of the bosR mutation on gene expression. WT
297, the bosR mutants, and the cis-complemented strains were
cultured at 37uC in BSK-H medium at pH 6.8, conditions under
which the RpoS regulon is highly induced [10,14–15,25]. Cells
were harvested at late-log phase and subjected to immunoblot and
RT-PCR analyses. As shown in Fig. 1, when bosR was inactivated,
the expression of rpoS, ospC and dbpA, was essentially abolished at
both the protein (Fig. 1A) and mRNA (Fig. 1B) levels. When the
bosR mutation was cis-complemented, gene expression was fully
restored.
To further investigate the influence of BosR on gene expression,
a bosR expression construct (pOY112) was created using a newly-
developed lac-based inducible expression system [45]. In pOY112,
bosR transcription was placed under the direct control of the
IPTG-inducible PpQE30 promoter. Bb 297 transformed with
pOY112 were cultivated in the presence of various amounts of
IPTG. Late log-phase cells were harvested and analyzed by
immunoblot. Relative to protein levels in cells grown in medium
without IPTG, 50 mM of IPTG induced the production of BosR,
as well as increased the levels of RpoS, OspC, and DbpA (Fig. 1C),
suggesting that BosR activates expression of these genes. Gene
Table 1. Infectivity of Bb clones in mice.
Strain, clone Description Dose
No. of cultures positive/total No. of specimens
examined
No. of mice infected/total No. of
mice
Heart Joint Skin All sites
297 wild-type Bb 10
4 9/9 9/9 9/9 27/27 9/9
OY08/A11 bosR mutant 10
4 0/6 0/6 0/6 0/18 0/6
OY08/F4 bosR mutant 10
4 0/7 0/7 0/7 0/21 0/7
OY08/A11 bosR mutant 10
7 0/10 0/10 0/10 0/30 0/10
OY08/F4 bosR mutant 10
7 0/6 0/6 0/6 0/18 0/6
OY33/A6 complement 10
4 6/6 6/6 6/6 18/18 6/6
OY33/F7 complement 10
4 6/6 6/6 6/6 18/18 6/6
Data were collected from three independent experiments.
doi:10.1371/journal.ppat.1001272.t001
Figure 1. BosR activates the expression of rpoS, ospC and dbpA. (A, B) Gene expression in spirochetes grown in BSK-H medium (pH 6.8) at
37uC was assessed by immunoblot (A) and RT-PCR (B). Lane 1, WT 297; lane 2, bosR mutant OY08/A11; lane 3, bosR mutant OY08/F4; lane 4,
complement OY33/A6; lane 5, complement OY33/F7. (C) Induction of bosR by IPTG leads to increased production of RpoS, OspC and DbpA. WT 297
containing the IPTG-inducible bosR construct (pOY112) was grown with various concentrations of IPTG. Cells were harvested at late-log phase and
analyzed by immunoblot. (D) Complementation of bosR mutation in trans rescues gene expression. The bosR mutant OY08/A11 harboring pOY112
was grown with varying IPTG. Cells were analyzed by immunoblot. Specific antibodies, indicated as a-, used in the immunoblot are indicated on the
left. FlaB was used as a normalization control for equivalent loading.
doi:10.1371/journal.ppat.1001272.g001
Borrelia burgdorferi BosR
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various concentrations of IPTG) was not altered (data not shown).
We also complemented the bosR mutation in trans using the IPTG-
inducible bosR expression construct pOY112. As shown in Fig. 1D,
when BosR was expressed from pOY112 by IPTG, expression of
RpoS, OspC and DbpA was consequently restored.
These data, consistent with previous studies [32–34], further
corroborate that BosR activates the expression of rpoS, ospC and
dbpA. Of note, expression of rrp2, rpoN or bb0646 (the gene
downstream from bosR in the bb0648-bosR-bb0646 operon) was not
affected by the bosR mutation (Fig. 1B), implying that the
phenotypes observed were not due to impairment in the
expression of rrp2, rpoN,o rbb0646. In addition, NapA levels were
found to be similar in WT, the bosR mutant, and the
complemented strains (Fig. 1A).
BosR controls ospC and dbpA expression through RpoS
Although our data suggested that the expression of both ospC
and dbpA was activated by BosR, it remained unknown how BosR
controlled the expression of these two lipoproteins. Given our
finding that rpoS transcription was abolished in the bosR mutant,
and the observations that expression of ospC and dbpA are directly
regulated by RpoS through RpoS-specific promoters [46–48], we
hypothesized that BosR likely regulated the expression of rpoS
which, in turn, influences ospC and dbpA. To test this hypothesis, an
IPTG-inducible rpoS expression construct was generated to render
RpoS synthesis independent of BosR. This vector, pOY110, was
then introduced into the bosR mutant OY08/A11. When RpoS
was induced from pOY110 by IPTG, expression of OspC and
DbpA was consequently rescued, although expression of BosR was
absent (Fig. 2), suggesting that the controlled induction of RpoS
could overcome the BosR deficiency and that BosR indirectly,
rather than directly, controls OspC and DbpA expression.
Recombinant BosR purification and metal content
analysis
Recombinant BosR (rBosR) was hyper-expressed in E. coli and
purified to apparent homogeneity. SDS-PAGE analysis indicated
that BosR has an apparent molecular mass of ,18.7 kDa (Fig. 3A),
which is in agreement with the apparent mass of native BosR in
Bb (Fig. 3B). Furthermore, when analyzed by size-exclusion
chromatography, purified BosR eluted predominantly as a dimer
with a molecular mass of ,38 kDa (Fig. 3C). Although
recombinant BosR has been obtained previously and Zn
2+ was
found to affect BosR’s in vitro binding to DNA [28–29], it remained
unclear whether BosR contains bound metal. Therefore, metal
content analysis was carried out by inductively coupled plasma
atomic emission spectrometry (ICP-AES) [27,49]. rBosR did not
contain detectable levels (,0.001 ppm) of metal ions such as Fe or
Mn (Fig. 3D). Rather, it contained 1.4 mol of zinc per mol of
protein. Moreover, in order to remove bound metal(s) from BosR,
we also dialyzed the protein in the presence of 10 mM EDTA.
However, 0.3 mol of zinc/mol of proteins remained in the
demetallated BosR (Fig. 3D), suggesting that the recombinant
protein bound zinc avidly. Of note, these properties are typical of
the dimeric bacterial Fur protein [50] or the Bacillus subtilis H2O2
stress response regulator PerR [51].
BosR directly impacts rpoS expression
In silico analysis predicted that Bb BosR contains an N-terminal
winged helix-turn-helix DNA binding domain and a C-terminal
dimerization domain. Three-dimensional (3D) protein modeling
using the Swiss-model program (http://swissmodel.expasy.org/)
indicated that the structure of the DNA-binding domain of BosR is
quite similar to the Vibrio cholerae Fur protein [52] and the B. subtilis
PerR protein [51] (Fig. S3), suggesting that, consistent with
previous reports [28–29], BosR may be a DNA-binding protein.
Moreover, our aforementioned data revealed that BosR impacted
rpoS expression at the transcription level. Thus, EMSAs were
performed to examine potential interactions between BosR and
the rpoS promoter. Consistent with previous studies [28–29], BosR
bound to the promoter of Bb napA (from 2336 to +48, relative to
the ATG start codon) (Fig. 4A). However, BosR did not bind to
the ospC or dbpBA promoters under our tested conditions (Fig. 4B
and C), providing support that BosR likely does not impact ospC
and dbpA directly. Although BosR did not bind to the probe
ZM126 that encompasses the rpoS promoter from 267 to 28
(Fig. 4D), BosR, in a dose-dependent manner, bound to the rpoS
promoter (PrpoS) encompassing 277 bp of the rpoS upstream region
and 245 bp of the rpoS encoding region (Fig. 5A). Of note, binding
of rBosR generated multiple shifted bands, suggesting the possible
existence of multiple BosR binding sites (BSs) in the probe. As an
initial approach to identify the BosR binding sequence, DNase I
footprinting assays were performed. As shown in Fig. 5B, three
BosR BSs were recognized in the PrpoS DNA. Specifically, BosR
BS1, BS2, or BS3 spanned regions of 2193 to 2137, 2120 to
246, or 229 to +43 (relative to the ATG start codon, where A is
+1), respectively (Fig. 5C).
To corroborate the DNase I-footprinting data, EMSA employ-
ing synthesized double-stranded (ds) DNA oligonucleotides
Figure 2. Induction of rpoS by IPTG results in the synthesis of
OspC and DbpA in the bosR mutant. The bosR mutant OY08/A11
harboring the IPTG-inducible rpoS construct (pOY110) was grown at
37uC with various concentrations of IPTG and gene expression was
analyzed by SDS-PAGE (A) and immunoblot (B). Approximate molecular
masses are indicated at the left in kDa. The arrow in (A) indicates the
position of OspC in SDS-PAGE. Specific antibodies, indicated as a-, used
in the immunoblot (B) are indicated on the left.
doi:10.1371/journal.ppat.1001272.g002
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Fig. 6B and C, BosR bound strongly to both ZM132 (representing
BS1) and ZM127 (representing BS2). Moreover, the binding of
BosR to labeled BS1 (ZM132) or BS2 (ZM127) was inhibited by
the addition of a 200-fold excess of unlabeled DNA, but not
inhibited by the addition of a 200-fold excess of non-specific
competitor ZM126 DNA (Fig. 6D and E), suggesting that BosR
binds to BS1 (ZM132) or BS2 (ZM127) specifically. Binding to
both probes also was abrogated by the addition of a-BosR
antibody, but not by the addition of control rat serum (Fig. 6D and
E), indicating that the DNA shift was indeed caused by BosR. Of
note, BosR, like Fur or PerR, putatively comprises an N-terminal
DNA binding motif domain and a C-terminal domain involved in
protein dimerization. Both domains are essential for Fur/PerR
recognizing and binding to its target DNA as a homodimer [51–
52]. Therefore, interaction with either domain of BosR by
antibody may also interrupt protein binding to DNA and prevent
DNA-BosR complex formation. Similarly, we also examined the
binding of BosR to BS3 using EMSA. As shown in Fig. 7, although
BosR did not bind to probe ZM160 that corresponds to the 59
sequence of BS3, the protein bound to probe ZM161 (encom-
passing rpoS from +4t o+63).
Figure 3. Analyses of purified recombinant BosR. (A) 12.5% (w/v) SDS–PAGE of purified recombinant BosR (right lane). Molecular masses are
indicated in the left lane in kDa. (B) Native BosR in Bb cultivated in BSK-H at 37uC was probed with a-BosR. Right lane: molecular mass markers; left
lane: Bb lysates. (C) Size exclusion chromatogram of purified BosR on a Superdex 200 column. Protein molecular mass standards used to calibrate the
gel-filtration column are indicated by arrows (aldolase =158 kDa; ovalbumin =43 kDa; ribonuclease A =13.7 kDa). (D) Metal content analysis of
recombinant BosR. Metal content was determined by ICP-AES.
doi:10.1371/journal.ppat.1001272.g003
Figure 4. DNA-binding activity of recombinant BosR. BosR binds
to the napA promoter (A, PnapA), but not to the promoters of ospC (B,
PospC), dbpBA (C, PdbpBA), or probe ZM126 (D). 30 fmol of labeled DNA
was incubated with various concentrations of BosR. NS, non-specific.
doi:10.1371/journal.ppat.1001272.g004
Borrelia burgdorferi BosR
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sites
EMSAs employing target DNA sequences (representing the
three BosR binding sites) exposed to increasing concentrations of
rBosR were used as means of inferring BosR binding affinities for
the three binding sites. As shown in Fig. 6 and 7, concentrations
of 50, 20, or 200 nM of rBosR induced shifts by ZM132 (BS1),
ZM127 (BS2), or ZM161 (BS3), respectively, suggesting that
BosR has an affinity for these DNA targets in the order of
BS2.BS1.BS3. In addition, when 200 nM of rBosR was used,
only a slight proportion (,10%) of ZM161 (BS3) was shifted
(Fig. 7), and probe ZM161 could not be saturated even by
10,000 nM of BosR (data not shown). To more precisely assess
the affinity of BosR for BS1 and BS2, we measured the amount of
bound DNA as a function of BosR concentration in EMSA assays
(Fig. 8A). The dissociation binding constants (Kd) for BS1
(ZM132) or BS2 (ZM127) were 210.2 or 36.6 nM, respectively.
The relative affinities of these two DNA elements for BosR were
also assessed by competition EMSA analysis (Fig. 8, B and C).
Binding of labeled BS1 or BS2 was not inhibited by the non-
specific competitor ZM126 (NS), but was inhibited by unlabeled
(cold competitor) BS1 or BS2, respectively. Moreover, binding of
labeled BS1 was inhibited approximately 90% by the addition of
200-fold unlabeled BS1, but was completely competed out by 50-
fold unlabeled BS2 (Fig. 8B). The addition of 200-fold of
unlabeled BS1 competed out only 15% of BS2 binding (Fig. 8C).
These data indicate that BosR has a higher affinity for BS2 than
for BS1.
Identification of a novel direct repeat sequence critical
for BosR binding
In silico analysis indicated that BosR contained two potential
CX2CZ n
2+ binding motifs in its C-terminus (located at residues of
114–117 and 153–156). These types of Zn
2+ structural sites are
crucial for Fur dimerization and binding DNA as a homodimer
[30,53]. Accordingly, we found that BosR bound Zn tightly
(Fig. 3D). Moreover, consistent with previous observations [28],
our purified BosR appeared to exist principally as a dimer in
solution (Fig. 3). Therefore, BosR may bind to the rpoS promoter
as a homodimer, suggesting that the BosR binding sequence(s)
may be a direct repeat (DR) sequence. In agreement with this
assumption, close inspection of the three BosR BSs revealed a DR
sequence (TAAATTAAAT) (Fig. 5C). Of note, this sequence also
consists of two contiguous pentamer direct repeats (TAAAT).
More specifically, BS1 contains one perfect DR at its 59 sequence
and one imperfect DR at its 39 sequence; BS2 contains one perfect
DR and one imperfect DR in the sequence upstream of the -24/
-12 RpoN binding site; and BS3 contains one imperfect DR
sequence at its 39. Of note, in both BS1 and BS2, the DR1 and
DR2 are located on opposite DNA strands.
We hypothesized that if the DR is essential for binding to
BosR, mutational changes in the sequence should abolish or
Figure 5. BosR binds to the rpoS promoter. (A) In a typical EMSA, 30 fmol of digoxigenin-labeled rpoS promoter (PrpoS) was incubated with the
indicated concentrations of BosR at 37uC for 30 min. Probe name is indicated at the position of unbound DNA. Bound DNA is denoted by arrows. (B)
DNase I footprinting analysis of the PrpoS probe with BosR. Lanes A, T, G and C represent sequencing ladders. Lane 1–5 contains 0, 200, 500, 1000,
1500 nM of BosR, respectively. The protected regions are marked on the right. (C) A summary of the DNase I footprinting assay results. The -24/-12
s
54 promoter sequence and the ATG start codon are indicated in boldface. The rpoS transcription start site is marked by the asterisk. The BosR
protected regions (BS1-3) are indicated with the dotted-line box. The predicted direct repeat (DR) sequence is underlined.
doi:10.1371/journal.ppat.1001272.g005
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two DNA fragments, ZM155 and ZM156, representing the 59 or
39 of BS1, respectively (Fig. 9A). Both ZM155 and ZM156
contain one DR sequence. After labeling these DNA fragments
with digoxigenin, each DNA fragment was mixed with BosR and
EMSAs were performed. As shown in Fig. 9B, BosR bound to
both fragments. However, when the DR was mutated, the
binding of BosR to either DNA fragment was abolished (Fig. 9B),
strongly supporting the notion that the DR sequence is critical for
BosR binding.
Using this same strategy, we also examined the two DRs in
BS2. As shown in Fig. 10, although BosR still bound to probe
ZM149 having sequences downstream of the -24/-12 site
scrambled, BosR binding to BS2 was abolished when sequences
upstream of the -24/-12 site were scrambled (ZM147), suggesting
that the functional BosR binding sites are located in the sequence
upstream of the -24/-12 site. Because sequences flanking the
binding motif often play important roles in protein-DNA
interactions, we synthesized another dsDNA (ZM212) to
represent the 59 of BS2, allowing added flanking sequences to
Figure 6. Binding of BosR to various probes containing the DNase-I protected regions. DNase-I protected regions are as indicated in Fig. 5.
30 fmol of digoxigenin-labeled probes were used in EMSAs. Probe names are indicated at the position of unbound DNA, while bound DNA is denoted
by arrows. (A) Detailed sequences of probes representing BS1 and BS2. The DRs are underlined. (B, C) The concentration of BosR is designated above
each lane. (D, E) 0 (2)o r5 0n M( +) of BosR was used in EMSA. Inclusion (+) or exclusion (2) of competitor DNA or serum are shown as indicated.6:
fold.
doi:10.1371/journal.ppat.1001272.g006
Figure 7. BosR binds to BS3 in PrpoS. (A) Probes were synthesized to represent the 59 or 39 sequences of BS3. The predicted DR is underlined. (B)
EMSAs. The concentration of BosR (nM) is designated above each lane. Probe name is indicated below the image. Bound DNA is denoted by arrows.
doi:10.1371/journal.ppat.1001272.g007
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bound to probe (ZM213) with the DR1 mutated (Fig. 10B). When
a mutation was introduced into DR2 (ZM214), BosR binding was
dramatically reduced (Fig. 10B). Moreover, when both DR
sequences were mutated, protein binding was completely
abolished (Fig. 10B). These data suggest that DR1 and DR2 in
BS2 are required for BosR binding.
Genome-wide distribution of the DR sequence essential
for BosR binding
To identify other Bb genes potentially regulated by BosR,
Katona et al. [28] performed a BlastN analysis based on the Per
box consensus sequence. However, the DR identified in our
current study is disparate from the Per box. To uncover
additional BosR-regulated genes, we searched the Bb genome
by using the Regulatory Sequence Analysis Tools (http://rsat.
ulb.ac.be/rsat), and queried for genes containing a perfect DR
sequence in putative promoter regions. Gene promoter regions
were defined as sequences from 2400 to +50 bp (relative to the
ATG start codon). The results are shown in Table 2. A total of
60 Bb genes were found to harbor one or multiple perfect DR
sequence in their promoter regions. Thirty-one genes were
located on the main chromosome, and 29 genes were on linear or
circular plasmids. Of the 31 chromosomal genes, 16 genes
encode proteins with assigned functions and15 genes encode
hypothetical proteins. More importantly, 13 of these genes were
found to be regulated by BosR in our recent microarray analysis
[34], further supporting that the DR sequence is important for
BosR binding.
Previously, BosR was reported to bind to the Bb napA promoter
(PnapA). Using footprinting assays, Boylan et al. [29] found that
BosR protected a 50-bp region located at -222 to -173 (relative to
the ATG start codon) in PnapA. Katona et al. [28], using EMSAs,
reported that BosR also bound to a DNA fragment encompassing
PnapA from 2152 to +3. In addition, the latter researchers also
reported that BosR bound to upstream regions of bosR.
Interestingly, these two genes were not identified in our search
(Table 2). However, when scrutinizing the upstream regions of
bosR and napA, multiple imperfect DR sequences were detected
(Fig. 11A, 12A). Therefore, EMSAs using synthesized dsDNA
were employed to examine the roles of these imperfect DR
sequences in BosR binding. Specifically, two dsDNA fragments,
ZM215 and ZM217, were used to represent the BosR binding
region in PnapA identified in previous studies [28–29]. As shown in
Fig. 11B, BosR bound to both DNA fragments. When a mutation
was introduced into the DR, binding of BosR to each probe was
abolished. Similar data were also obtained for the probe ZM219
representing the bosR upstream region; BosR binding to the probe
was abolished when the predicted DR was mutated (ZM220)
(Fig. 12B). These data further substantiate the critical role of the
DR in BosR binding.
BosR and RpoN bind to distinct sites in the rpoS
promoter regions
Bb RpoN activates rpoS directly through a canonical -24/-12
promoter, and mutation of G at -24 to T in the rpoS promoter
resulted in a significant diminishment of in vitro RpoN binding and
a dramatic decrease in rpoS expression [8,11,24]. Our analysis of
BS2, the site exhibiting the highest affinity for BosR among the
three BosR binding sites in the rpoS promoter, revealed that a
perfect DR sequence is located just upstream and adjacent to the
-24/-12 s
54 promoter (Fig. 13A). Given the importance of this
locus for rpoS transcription, we further examined this site more
closely using EMSA. As shown in Fig. 13B, when nucleotides in
the -24/-12 site were mutated (ZM157, mutations of G-24T, G-
25T, and C-12A), the binding of BosR was not altered. In contrast,
Figure 8. Comparison of the relative affinity of BosR for BS1
(ZM132) and BS2 (ZM127). (A) 30 fmol of labeled probe was
incubated with various concentrations of BosR (nM). The membrane
containing the bound and unbound DNA was detected using an
enzyme immunoassay, and exposed to a Fujifilm LAS-3000 Imager
(Fujifilm). Images were analyzed by using the MultiGauge V3.0 software
(Fujifilm), and bands were quantified to determine the affinity of BosR
for probes. (B) Competition of labeled BS1 (ZM132) with various
amounts of unlabeled BS1, BS2, or non-specific (NS) DNA. (C)
Competition of labeled BS2 (ZM127) with various amounts of unlabeled
BS1, BS2, or NS DNA. In (B) and (C), 100 nM of BosR was used in EMSAs,
and bound and unbound DNA was measured as described in (A). NS:
non-specific competitor (ZM126).
doi:10.1371/journal.ppat.1001272.g008
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PLoS Pathogens | www.plospathogens.org 8 February 2011 | Volume 7 | Issue 2 | e1001272Figure 9. The DRs in BS1 are essential for BosR binding. (A) Detailed sequences of probes representing BS1. The DRs are underlined.
Scrambled sequences are italicized. Mutated nucleotides are indicated in boldface. (B) EMSAs. The concentration of BosR (nM) is designated above
each lane. Probe name is indicated below the image. Bound DNA is denoted by arrows.
doi:10.1371/journal.ppat.1001272.g009
Figure 10. Analysis of BosR binding to BS2. (A) Detailed sequences of probes representing BS2. The DRs are underlined. Scrambled sequences
are italicized. Mutated nucleotides are indicated in boldface. (B) EMSAs. The concentration of BosR (nM) is designated above each lane. Probe name is
indicated below the image. Bound DNA is denoted by arrows.
doi:10.1371/journal.ppat.1001272.g010
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ID Gene Function matching sequence
BB0007 hypothetical protein ttatTAAATTAAATtgtt
BB0008 conserved hypothetical protein ttatTAAATTAAATtgtt
BB0020 pfpB Pyrophosphate—fructose 6-phosphate 1-phosphotransferase, beta subunit atcaTAAATTAAATatta
BB0036 parE DNA topoisomerase IV tttaTAAATTAAATttta
BB0055 tpiA triosephosphate isomerase cagaTAAATTAAATttat
BB0086 conserved hypothetical protein gtttTAAATTAAATttcc
BB0097 hypothetical protein cactTAAATTAAATctca
BB0141 mtrC membrane fusion protein tttcTAAATTAAATgata
BB0141 aagaTAAATTAAATtatg
BB0259 hypothetical protein atttTAAATTAAATtcaa
BB0300 ftsA cell division protein atcaTAAATTAAATgctt
BB0306 conserved hypothetical protein ggttTAAATTAAATgaat
BB0322 hypothetical protein ttctTAAATTAAATtata
BB0323 hypothetical protein ttctTAAATTAAATtata
BB0337 eno enolase gtcaTAAATTAAATaatc
BB0524 inositol monophosphatase ttgaTAAATTAAATattt
BB0564 hypothetical protein aggtTAAATTAAATttaa
BB0564 ttggTAAATTAAATttta
BB0565 cheW-2 purine-binding chemotaxis protein ttggTAAATTAAATttta
BB0565 aggtTAAATTAAATttaa
BB0578 mcp-1 methyl-accepting chemotaxis protein gtttTAAATTAAATtaaa
BB0578 aaatTAAATTAAATtaaa
BB0578 atttTAAATTAAATttac
BB0580 conserved hypothetical integral membrane protein ataaTAAATTAAATgacc
BB0592 hypothetical protein aaaaTAAATTAAATtgag
BB0601 glyA serine hydroxymethyltransferase caatTAAATTAAATattt
BB0608 pepD aminoacyl-histidine dipeptidase attaTAAATTAAATccaa
BB0608 tgatTAAATTAAATccat
BB0668 flaA flagellar filament outer layer protein ttgaTAAATTAAATttta
BB0672 cheY-3 chemotaxis response regulator cttcTAAATTAAATtttg
BB0739 hypothetical protein aaatTAAATTAAATattt
BB0771 rpoS RNA polymerase sigma factor ttttTAAATTAAATtggc
BB0771 attgTAAATTAAATcggc
BB0791 tdk thymidine kinase atacTAAATTAAATaac
BB0798 putative competence protein F atatTAAATTAAATgagt
BB0846 hypothetical protein aaaaTAAATTAAATataa
BB0849 hypothetical protein aaaaTAAATTAAATataa
BB0851 putative exported protein atctTAAATTAAATtgat
BBA05 antigen, S1 ttcaTAAATTAAATtacc
BBA33 hypothetical protein gaaaTAAATTAAATtttc
BBB03 hypothetical protein atatTAAATTAAATtata
BBB29 malX PTS system, maltose and glucose-specific IIABC component atttTAAATTAAATttag
BBC06 eppA exported protein A tttcTAAATTAAATattt
BBF01 erpD protein, putative ctccTAAATTAAATaaaa
BBF22 protein p23, putative tttaTAAATTAAATaaaa
BBF24 plasmid partition protein, putative gaaaTAAATTAAATtcac
BBG02 conserved hypothetical protein aaagTAAATTAAATaaca
BBG08 plasmid partition protein, putative taaaTAAATTAAATtctt
BBI16 hypothetical protein taatTAAATTAAATattt
BBI16 taatTAAATTAAATaaat
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-24/-12 site (ZM166, AATT replaced by GGCC), BosR binding
was abolished (Fig. 13). These data strongly suggest that the key
nucleotides for the binding of BosR and s
54 to the rpoS promoter
are different.
Discussion
The essential role of the RpoN-RpoS pathway for virulence
expression by the Lyme disease bacterium is now well documented
[8–11,13,16–17,24–25]. However, a number of the molecular
ID Gene Function matching sequence
BBI36 antigen, P35, putative acttTAAATTAAATacta
BBI37 hypothetical protein acttTAAATTAAATacta
BBI38 hypothetical protein acttTAAATTAAATacta
BBI39 hypothetical protein acttTAAATTAAATatta
BBJ32 hypothetical protein ttttTAAATTAAATgaat
BBJ39 hypothetical protein aaccTAAATTAAATatta
BBJ40 hypothetical protein aaccTAAATTAAATatta
BBJ41 antigen, P35, putative acctTAAATTAAATatta
BBK18 conserved hypothetical protein tccaTAAATTAAATcaat
BBL04 hypothetical protein gagaTAAATTAAATttta
BBM09 conserved hypothetical protein aaagTAAATTAAATccga
BBN41 hypothetical protein gaacTAAATTAAATgaag
BBO04 hypothetical protein gagaTAAATTAAATttta
BBO09 conserved hypothetical protein aaagTAAATTAAATccga
BBO33 conserved hypothetical protein tattTAAATTAAATagat
BBP04 hypothetical protein gagaTAAATTAAATttta
BBQ72 hypothetical protein taatTAAATTAAATccat
BBS04 hypothetical protein gagaTAAATTAAATttta
1, Candidate genes were identified by searching B. burgdorferi B31 genome using ‘‘Regulatory Sequence Analysis Tools’’. Gene promoter was defined as the region
encompassing sequences from -400 to +50 (relative to a putative translation start ATG).
2, Four flanking nucleotides are also shown.
doi:10.1371/journal.ppat.1001272.t002
Table 2. Cont.
Figure 11. The DRs in PnapA are required for BosR binding. (A) Detailed sequences of the probes used in EMSAs. PnapA1 represents the BosR-
protected region identified by Boylan, et al. [29]. PnapA2 represents the probe used by Katona, et al. [28]. The DRs are underlined. Mutated
nucleotides are indicated in boldface. (B) EMSAs. The concentration of BosR (nM) is designated above each lane. Probe name is indicated below the
image. Bound DNA is denoted by arrows. The numbers in parenthesis indicate numbers of omitted nucleotides (dash lines) between the probe and
the ATG start codon.
doi:10.1371/journal.ppat.1001272.g011
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obscure. Whether Rrp2, as an EBP, is present as a dimer and
assembles into a functional hexamer or heptamer when activated
is unknown. It is also unclear how Rrp2 interacts with Es
54 to
modulate RpoN-dependent rpoS expression in the absence of
demonstrable specific binding to the rpoS promoter or upstream
region [8,24], but there is precedence for this anomaly in another
bacterial pathogen, Campylobacter jejuni (its EBP FlgR activates the
s
54-dependent flagellar genes independent of DNA-binding) [54].
Moreover, the mammalian host factors that influence rpoS
expression [12–13] have not been identified. Recently it was
shown in Bb strain B31 that a mutation in bosR led to a loss of
mouse infectivity, as well as a block in the expression of the
virulence-associated factors OspC and DbpA [32,34–35]. Given
that both ospC and dbpA are under the control of RpoS [46–48], we
proposed that BosR somehow was involved in the activation of the
RpoN-RpoS regulatory pathway [34]. However, these data and
the resultant hypothesis emanated from studies involving only one
virulent strain (strain B31) of Bb. It has long been established that
genetic regulators and control mechanisms can vary widely among
strains of the same virulent species of pathogenic bacteria [36–38].
Hence, the question remained whether the novel RpoN-RpoS
regulatory pathway and the important role of BosR were common
to other virulent strains of Bb. The results of our study herein now
confirm that the inactivation of bosR, which prevents activation of
the RpoN-RpoS pathway by blocking the expression of rpoS, and,
in turn, prevents expression of the virulence-associated genes ospC
and dbpA, is not unique to a single virulent strain of Bb. BosR and
its control over RpoN-RpoS activation thus appears to be an
important global regulatory pathway essential for virulence
expression by the Lyme disease spirochete.
Our findings also provide new insights into the function of
BosR. BB0647 (BosR) was originally predicted to be a Fur
homologue [7,28]. Given the lack of precedence for interplay
between a Fur homologue and an alternative sigma factor, such as
RpoN or RpoS, in other bacteria, it was entirely unexpected that
BosR would play a role in the induction of the RpoN-RpoS
pathway [32,34]. Furthermore, the nomenclature of ‘‘BosR’’, as
Borrelia oxidative stress regulator, was derived from the sequence
similarity of BosR to the B. subtilis PerR, and an observation [29]
that, in the heterologous E. coli, BosR activated the expression of
Bb napA implicated in the oxidative stress response [55]. It was
previously reported that NapA production was inhibited in a bosR
mutant of Bb, and that the mutant displayed an in vitro growth
Figure 13. Different key nucleotides are required for BosR or RpoN binding to the rpoS promoter. (A) Sequences of the probes used in
EMSAs. The DR is underlined. The -24/-12 region is indicated with the dotted-line box. Scrambled sequences are italicized. Mutated nucleotides are
indicated in boldface. (B) EMSAs. The concentration of BosR (nM) is designated above each lane. Probe name is indicated below the image. Bound
DNA is denoted by arrows.
doi:10.1371/journal.ppat.1001272.g013
Figure 12. Analysis of the DR in the upstream region of bosR. (A) Sequences of the probes used in EMSAs. The DR is underlined. Mutated
nucleotides are indicated in boldface. (B) EMSAs. The concentration of BosR (nM) is designated above each lane. Probe name is indicated below the
image. Bound DNA is denoted by arrows. The numbers in parenthesis indicate numbers of omitted nucleotides (dash lines) between the probe and
the ATG start codon.
doi:10.1371/journal.ppat.1001272.g012
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such growth defect, and the expression of napA was not
significantly altered in the bosR mutant [34]; these same wild-
type-like phenotypes were also observed in our current bosR
mutant derived from strain 297 (Fig. 1B, Fig. S2B). Given these
more recent findings, and the current paucity of compelling data
that directly link BosR to an oxidative stress response in Bb, it is
thus still premature to conclude that BosR is involved in
modulating oxidative stress in Bb. Finally, despite the character-
ization of BosR as a Fur homologue, it also remains unclear
whether BosR plays a role in regulating transition metal
homeostasis in Bb.
Our EMSA data clearly indicated that BosR binds to the rpoS
promoter, suggesting that BosR directly influences rpoS expres-
sion. Moreover, DNA footprinting assays revealed three BosR-
protected regions in rpoS. The occupation of multiple, rather than
one, binding sites might stabilize and secure BosR binding to the
rpoS promoter region. BosR exhibited binding affinity for these
three sites in the order of BS2.BS1.BS3. Among these three
sites, BS2 was found juxtaposed to and partially overlapping with
the -24/-12 RpoN binding site, whereas BS1 is located upstream
of BS2. BS3 is located in sequences downstream of BS2, or more
specifically, in the RpoS-encoding region. A previous study
revealed that, when Bb was grown in vitro,am i n i m a lP rpoS
(starting from the -24/-12 RpoN binding site), which contains
only one intact BosR BS (BS3), is able to express RpoS at the
same level as PrpoS containing all three BosR BSs [24].
Furthermore, RpoS expressed from the minimal PrpoS restored
mouse infectivity to the rpoS mutant [24]. These data imply that
PrpoS with only BS3 is sufficient to drive rpoS transcription,
suggesting that our data of BosR binding to BS3 may be
physiologically relevant. However, BS1 and BS2 may be required
to coordinate rpoS expression under different in vivo conditions of
the two diverse niches of Bb’s complex life cycle. Our
unanticipated finding that BS3 for BosR is located within the
RpoS-encoding region is rare but not unprecedented for
transcriptional activators; binding sites for other bacterial
regulatory proteins have been noted to occur in the coding
regions of their target genes [56–57]. It is thus possible that BS3
located in the rpoS encoding region may somehow strengthen the
binding of BosR to PrpoS, and then cooperate in opening the
RpoN-RNAP closed complex. Or, BosR binding at BS3 might
allow rpoS expression to be controlled more tightly, especially if
rpoS transcription requires transient modulation.
A major finding of this study is the identification of a novel
DNA binding sequence for BosR. As a Fur homologue, BosR
dimers were reported [28–29] to bind in vitro to the Bb napA
promoter, the upstream regions of bosR and bb0646, and DNA
containing a Fur box (GATAATGATAATCATTATC) or Per
box (TTATAAT-ATTATAA). In general, the Fur box is
interpreted as two 9-bp inverted repeats (GATAATGAT), or
two heptamer inverted repeats (TGATAAT), or three hexamer
repeats (GATAAT), whereas the Per box is recognized as two
inverted repeat (TTATAAT) [53,58]. Despite the facts that the
rpoS promoter contains neither a Fur (or Per) box, nor has
significant similarity with the Bb napA promoter or the upstream
sequences of bosR and bb0646, BosR binds to the rpoS promoter.
More importantly, we identified a DR sequence (TAAATTAAAT)
that is critical for BosR binding. This assertion is strongly
supported by several lines of evidence. First, the DR sequence is
present in all three BosR BSs. Second, the DR sequence was
identified in the promoter regions of 13 genes already known to be
influenced by BosR. Third, imperfect DR sequences are present in
previously-established BosR-binding DNA fragments, such as
PnapA and a bosR upstream region. Finally, mutations in the DR
severely reduced or completely abolished DNA binding by BosR.
Of note, the DR sequence is markedly different from the direct or
inverted repeats present in Fur or Per boxes. Thus, BosR appears
to be able to recognize different DNA sequences, including the Fur
box consensus, the Per box consensus, and the rpoS promoter
element (containing the DR sequence). Such promiscuous DNA
recognition activity has been observed previously for the
Bradyrhizobium japonicum Fur protein [59]; in addition to binding
to the Fur box consensus, B. japonicum Fur also binds in vitro to the
irr promoter (with similar affinity), but, the irr promoter does not
contain a Fur box. Rather, it contains three essential direct repeat
sequences of TGCATC that differ markedly from the direct
repeats (GATAAT) or inverted repeats (GATAATGAT) in the
Fur box [59]. The mechanistic details of this anomaly remain
unknown. One possibility for BosR is that its binding properties in
vitro may depend largely on DNA conformation. However, when
analyzing the conformation of the dsDNA (including DNA
containing mutated DRs) used in our EMSAs by PREDICTOR
(http://www.farwer.staff.shef.ac.uk/PREDICTOR), which is a
program calculating the three-dimensional atomic structure of
dsDNA, no obvious differences in DNA conformation were
revealed. Moreover, although BosR is predicted to share a similar
three dimensional structure with Fur and the PerR protein (Fig.
S3), BosR may harbor some subtle, unique structural feature(s)
(undetected by protein modeling) that confer its DNA binding
traits. Alternatively, under different in vivo conditions (tick vector or
mammalian hosts), BosR may display alternative structural
conformations that differentially regulate gene expression. As
such, differing conformations may prompt BosR to bind to
different DNA sequences (or with varying affinities). It is perhaps
noteworthy that, after decades of intensive work, there is still much
controversy over the molecular mechanisms and biochemistry of
how Fur operates as a transcriptional repressor [60]. Thus, it is not
surprising that there is yet much to learn regarding the molecular
mechanism(s) that allow BosR to act as a regulator. Nonetheless,
our finding that BosR, as a Fur or PerR homolog, recognizes
disparate DNA sequences not only hints that the well-established
model for Fur (or PerR)-DNA interaction may warrant further
refinements, but also suggests that BosR employs mechanisms
different from Fur or PerR to regulate gene expression. In
addition, the recognition that BosR depends on a novel direct
repeat for its binding to the rpoS promoter serves as a strong
foundation for further mechanistic studies.
Several aspects of our study engender a number of provocative
possibilities surrounding the function of BosR as a transcriptional
enhancer for rpoS. First, our mutagenesis experiments revealed that
different key nucleotides are required for BosR or RpoN binding
to the rpoS promoter, implying that BosR and RpoN may bind to
different faces of the DNA helix (comprising the rpoS promoter).
Second, that BS2 is immediately adjacent to the -24/-12 RpoN
binding site tempts speculation that BosR and RpoN (and possibly
Rrp2) may interact with one another at the -24/-12 site to initiate
rpoS transcription. However, results from E. coli-based two-hybrid
assays thus far have failed to show interactions between BosR and
RpoN (or Rrp2) (unpublished data). These results, however, are
not unexpected, because there is no precedence for interactions
between Fur/PerR proteins and RpoN or an EBP (e.g. Rrp2) in
any bacterial system. Despite that, it is not impossible that BosR
may transiently interact with RpoN or Rrp2 in vivo. It also remains
possible that BosR may act as a critical molecule to recruit Rrp2
and/or RpoN to the rpoS promoter and the Es
54-CC. The
binding of BosR dimers to one face of the rpoS promoter at
multiple sites may lead to DNA bending or other conformational
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54 to the -24/-12 site
on the other strand of the promoter.
BosR, Fur, and PerR share structural similarity (Fig. S3) and all
three are zinc- (or other metal-) containing regulatory proteins.
However, there are other key features of BosR that markedly
distinguish it from its putative Fur or PerR homologs. With Fur,
metal-dependent DNA binding acts primarily as a repressor to
avoid cellular iron toxicity [30,53,58,60]. Its positive regulatory
role is often indirect, via the Fur-regulated anti-sense regulatory
small RNA, RhyB [30,60]. In the case of PerR, transcriptional
activation of its target genes (involved in protecting the bacterial
cell against oxidative stress) occurs when the metal-bound PerR
dissociates from the promoter [51,60]. Of the three regulators,
BosR is the only one that works in concert with an alternative
sigma factor (RpoN) and an EBP (Rrp2), and the only one that
appears to activate gene transcription directly by DNA binding.
However, at this time we cannot rule out the less likely possibility
that BosR may prevent the binding of a repressor that blocks rpoS
transcription. Nonetheless, from the metal (zinc) content of rBosR,
it is tempting to speculate that BosR’s DNA-binding activity may
be metal-dependent. Although zinc was found in rBosR, the
question remains whether zinc is the physiologically relevant metal
that confers normal activity to native BosR. It is thus not out of the
realm of possibility that other metal(s) may be physiological
relevant during Bb’s existence in ticks or mammalian hosts.
Further studies are warranted to investigate these possibilities,
although many of the potential experimental approaches have
substantial obstacles.
Our findings also reveal a new aspect of bacterial s
54-
dependent gene activation and expands our understanding of
transcriptional regulation by alternative sigma factors in general.
Traditionally, for all known bacterial s
54-dependent genes,
transcriptional activation requires only the cognate activator
EBP (ATPase) [3–4]. For some s
54-dependent promoters,
maximal induction relies on one or several auxiliary factors. For
example, IHF, as a DNA-bending protein, can promote the
interaction between Es
54 and an EBP via DNA looping. In this
case, however, IHF acts only as an architectural element to
facilitate formation of the loop. It is the EBP, rather than the IHF
protein, that modulates s
54-dependent gene expression [61]. In E.
coli and Salmonella typhimurium, in the presence of arginine, the
arginine repressor ArgR can induce the expression of the s
54-
dependent astCADBE operon [62–63]. Nonetheless, ArgR plays
only an accessory, rather than essential, role in the expression of
astCADBE. In the absence of ArgR, genes are still expressed,
although at more moderate levels. In response to flavonoids, the
Azorhizobium caulinodans transcriptional activator NodD induces the
transcription of NifA-RpoN-controlled NodA operon at an early
stage [64]. In mature nitrogen-fixing nodules, the nodA gene is still
transcribed in the nodD mutant in response to nitrogen-oxygen
availability. In addition to the putative EBP (Rrp2), BosR is
directly involved in the transcriptional activation of s
54-dependent
rpoS in Bb. Unlike ArgR, NodD, and other accessory factors
involved in maximizing the induction of s
54-dependent genes,
BosR is essential for rpoS transcription in Bb. To our knowledge,
this is the only demonstration, in any bacterial s
54-dependent
transcriptional system, that transcription of a s
54-dependent gene
requires an additional transcriptional activator. Bioinformatics
indicate that homologues of BosR and s
54 are not only conserved
in other Borrelia species (such as B. garinii and B. afzelii), but may be
encoded in numerous other bacterial species including Bordetella,
Burkholderia, Shewanella, Campylobacter, Clostridium, Bacillus, Listeria,
and others. Given this wide distribution of BosR homologs, our
study may have broader significance in understanding the
regulatory control over RpoN- or RpoS-dependent genes in other
pathogenic bacteria.
Materials and Methods
Strains and culture conditions
Strains and plasmid used in this study are listed in Table 3.
Infectious Bb strain 297 [65] was used as the WT strain
throughout this study. Bb was routinely cultured at 37uC and
5% CO2 in either BSK-II medium [66] or BSK-H medium
(Sigma) supplemented with 6% rabbit serum (Pel-Freeze). When
appropriate, supplements were added to media at following
concentrations: kanamycin, 160 mg/ml; streptomycin, 150 mg/ml.
Spirochetes were enumerated by dark-field microscopy.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All animal procedures
were approved by Institutional Animal Care and Use Committee
at UT Southwestern Medical Center (Animal Protocol Number
0165-07-14-1).
Construction of bosR mutants and complement
The bosR mutant OY08 was created by allelic exchange in Bb
297 using a suicide vector pOY24 [34]. The mutation in bosR was
cis-complemented by transforming a suicide vector, pOY83 [34],
into the bosR mutant, generating OY33. Transformation of Bb was
performed as previously described [67]. Plasmid contents of all Bb
strains were determined by PCR using specific primers.
Generation of lac-inducible gene expression constructs
To artificially control BosR or RpoS expression in Bb, gene
expression constructs were generated using a newly-developed lac-
based inducible expression system [45]. First the PflaB-BblacI-
PpQE30 cassette from pJSB252 [45] was ligated into pJD54
digested with BglII and BamHI, which generated pOY99.2. Then
rpoS or bosR was amplified from Bb 297 and cloned into pOY99.2
digested with NdeI and BglII, generating pOY110 or pOY112,
respectively. In these constructs, rpoS or bosR transcription was
directly controlled by the IPTG-inducible T5 promoter in pQE30
(PpQE30).
Bb infection of mice
The infectivity of Bb clones was assessed using the murine
needle-challenge model of Lyme borreliosis [43–44]. C3H/HeN
mice (Charles River Laboratories) were infected via intradermal
injection with various concentrations of Bb. At 4 weeks post
inoculation, mice were sacrificed and skin, heart, and joint tissues
were collected and cultured in BSK supplemented with 16Borrelia
antibiotic mixture (Sigma). The outgrowth of spirochetes in these
cultures was assessed using darkfield microscopy.
Recombinant BosR expression and purification
Recombinant BosR was produced in E. coli using the
Champion pET SUMO protein expression system (Invitrogen).
Briefly, bosR was amplified using primers ZM69F and ZM69R,
and ligated into pET SUMO vector through TA cloning such
that the resultant construct pOY73 encoded a fusion protein with
aH i s 6 –SUMO tag at its N terminus. Constructs were confirmed
using PCR amplification, restriction digestion, and sequence
analysis. The resulting construct, pOY73, was then transformed
into E. coli strain BL21-DE3. After induction with 1 mM IPTG
Borrelia burgdorferi BosR
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using a Ni-NTA spin column under native conditions according
to the manufacturer’s instruction (Qiagen). The N-terminal His6
–SUMO tag was removed via cleavage with SUMO protease
(Invitrogen) at 30uC for 4 h in the buffer A containing 20 mM
Tris, 20 mM NaCl, 100 mM L-arginine, pH 7.5. The protease
digestion mixture was concentrated and buffer exchanged with
buffer A using an Amicon ultracentrifuge filter device (Millipore)
with a 10,000 molecular weight exclusion limit. The concentrated
protein was applied to a HiLoad 16/60 Superdex 200 prep grade
column and purified on an A ¨kta fast performance liquid
chromatography system (GE Healthcare) using buffer A.
Subsequent to elution, peak fractions were analyzed by SDS-
PAGE and Western Blot. At this stage, the protein was pure to
apparent homogeneity and predominantly present as dimer.
Fractions containing pure BosR with a homogeneity .95% were
pooled. Protein concentration was determined using the BCA
protein assay kit (Thermo Scientific). Rat polyclonal antibody
against BosR, Ab-BosR, was generated as previously described
[34].
Metal content analysis
Metal contents in protein or buffer solutions (as references) were
measured using inductively coupled plasma atomic emission
spectrometry (ICP-AES), by the Research Analytical Laboratory,
University of Minnesota. Proteins were demetallated by dialyzing
samples with 10 mM ETDA for 24 h, as described previously
[49]. Three independent tests were performed, and average metal
concentrations with standard deviations were presented.
SDS-PAGE and immunoblot analysis
SDS-PAGE and immunoblot analysis were carried out as
previously described [34]. Briefly, purified protein samples or a
Table 3. Strains and plasmids used in this study.
Strain or plasmid Description Source
Strains
B. burgdorferi
297 infectious, low-passage B. burgdorferi [65]
OY08/A11 Bb 297, DbosR::Kan This study
OY08/F4 Bb 297, DbosR::Kan This study
OY33/A6 OY08/A11 transformed with pOY83, complemented strain This study
OY33/F7 OY08/F4 transformed with pOY83, complemented strain This study
OY57 OY08/A11 transformed with pOY110 This study
OY62 OY08/A11 transformed with pOY112 This study
E. coli
TOP10 F
2 mcrA D(mrr-hsdRMS-mcrBC) f80lacZDM15 DlacX74 recA1 araD139 D(ara-leu)7697 galU galK rpsL (Str
R)
endA1 nupG
Invitrogen
BL21 (DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Invitrogen
reporter strain D(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac [F’ laqI
q bla lacZ Kan
r] Agilent
Plasmids
pJD54 B. burgdorferi/E. coli shuttle vector with PflgB-aadA [68]
pBT cloning vector Agilent
pTRG cloning vector Agilent
pBT-LGF2 lcI-Gal4 fusion Agilent
pTRG-Gal11p aRNAP-Gal11 fusion Agilent
pJSB252 pJD7::PpQE30-Bbluc+ and PflaB-BblacI (divergent); [45]
pET SUMO protein expression vector Invitrogen
pOY24 plasmid used to create bosR mutation [34]
pOY63 promoterless lucBb+ from pJD48 cloned into pJD54 [47]
pOY73 bosR cloned into pET SUMO This study
pOY83 plasmid used to complement bosR mutation [34]
pOY99.2 the PflaB-BblacI-PpQE30 cassette from pJSB252 cloned into pJD54 This study
pOY110 Bb 297 rpoS cloned into pOY99.2 This study
pOY112 Bb 297 bosR cloned into pOY99.2 This study
pOY135 Bb bosR cloned into pBT This study
pOY136 Bb rrp2 cloned into pBT This study
pOY137 Bb bosR cloned into pTRG This study
pOY138 Bb rrp2 cloned into pTRG This study
pOY139 Bb rpoN cloned into pTRG This study
doi:10.1371/journal.ppat.1001272.t003
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7 spirochetes were
loaded per lane on a 12.5% acrylamide gel. Resolved proteins
were either stained with Coomassie brilliant blue or transferred to
nitrocellulose membrane for immunoblot analysis. BosR was
detected using the anti-BosR rat polyclonal antibody, Ab-BosR.
Rrp2, RpoS, OspC, and DbpA were detected using anti-Rrp2
monoclonal antibody 5B8-100-A1, anti-RpoS monoclonal anti-
body 6A7-101, anti-OspC monoclonal antibody 1B2-105A, or
anti-DbpA monoclonal antibody 6B3, respectively. To confirm
equal loading of bacteria in each lane, immunoblotting for the
flagellar core protein (FlaB) was performed using a chicken IgY
anti-FlaB antibody. Immunoblots were developed colorimetrically
using 4-chloro-1-napthol as the substrate or by chemiluminescence
using ECL Plus Western Blotting Detection system (Amersham
Biosciences).
Electrophoretic mobility shift assay (EMSA)
Primers used in EMSA are listed in Table S1. PCR-
amplified or synthesized DNA probes were end-labeled with
digoxigenin using recombinant terminal transferase (Roche
Applied Science). The labeled probe (30 fmol) was mixed with
various amounts of purified BosR in 20 mlo ft h eg e ls h i f t
binding buffer containing 20 mM Hepes (pH 7.5), 50 mg/ml
poly[d(A-T)], 5% (w/v) glycerol, 1 mM DTT, 100 mg/ml BSA,
1m MM g C l 2, and 50 mM KCl. After being incubated at 37uC
for 30 min, the samples were analyzed by 5% non-denaturing
polyacrylamide gel electrophoresis at 80V for 1–3 h. Then
DNA was transferred onto a positively charged Nylon
membrane (Roche Applied Science, USA) by electroblotting.
The digoxigenin-labeled probes were subsequently detected by
an enzyme immunoassay using an antibody (anti-digoxigenin-
AP, Fab fragments) and the chemiluminescent substrate
disodium 3-(4-methoxyspiro {l,2-dioxetane-3,29-(59-chloro)tri-
cyclo[3.3.1.1
3,7]decan}-4-yl) phenyl phosphate (CSPD) (Roche
Applied Science, USA).
DNase I footprinting assays
For DNase I footprinting, DNA probe (PrpoS) containing the
rpoS promoter was PCR-amplified using primers 88F and 88R.
The resultant DNA was labeled with T4 polynucleotide kinase
(NEB) and c-
32P-ATP (PerkinElmer). A 50-ml reaction contain-
ing the radiolabeled probe (300 fmol) and various amounts of
BosR was incubated in the gel shift binding buffer at 37uCf o r
30 min. Then incubated DNA was digested with 0.01 unit of
DNase I (Invitrogen) at room temperature for 2 min. The
reaction was terminated by adding 100 mlo fD N a s eIs t o p
solution containing 200 mM Tris-HCl (pH 7.5), 50 mM EDTA,
2% SDS, 200 mg/ml of proteinase K, and 250 mg/ml of
glycogen, followed by phenol/chloroform extraction. Then
DNA was precipitated with 20 ml of 3M ammonium acetate,
and 600 ml of 100% ethanol at 220uC overnight. The
precipitated DNA was washed with 70% ethanol and air-dried.
The pellet was resuspended in 10 ml of formamide dye (90%
formamide, 16 TBE, and 0.02% bromophenol blue/xylene
cyanol) and analyzed in a 6% polyacrylamide/7 M urea gel at
75 W for 2 h. The gel was transferred onto a chromatography
paper (Fisher), dried, and exposed in a PhosphorImager screen.
The signals were detected by Typhoon 9200 PhosphorImager
(GE Healthcare).
RNA isolation and RT-PCR
Spirochetes were grown in BSK at 37uC under 5% CO2, and
harvested when bacterial growth reached a density of 5610
7 cells
per ml. Total RNA was isolated using Trizol (Invitrogen)
according to the instructions. After genomic DNA was digested
using RNase-free DNase I (GenHunter Corporation), RNA was
further purified using RNeasy Mini Kit (Qiagen). cDNA was
generated from 1 mg of RNA using the SuperScript III Platinum
Two-step qRT-PCR kit according to the manufacturer’s protocol
(Invitrogen).
Supporting Information
Figure S1 Construction of bosR mutants (bosR
2) and comple-
mented strains (bosR
2/+). (A) Schematic drawings of wild type
(WT), the bosR mutant, and the complemented strain at the loci of
bb0645-bb0649. (B) RT-PCR indicate that bb0646, bosR, and
bb0648 are co-transcribed. lane 1, primer pair a1 and b1 in control
PCR using RNA as template; lane 2, primer pair a1 and b1 in
ordinary PCR using genomic DNA as template; lanes 3-6, cDNA
was used as template; lane 3, primer pair a1 and b1; lane 4, primer
pair b3 and b4; lane 5, primer pair b3 and c1; lane 6, primer pair
a1 and c1; lane 7, primer pair a1 and c1 using genomic DNA as
template. (C) PCR analysis of WT 297, bosR mutants, and the
complemented strains. The bosR-specific primer pairs used in PCR
are indicated on the right. Lane 1, WT 297; lane 2, bosR
2 OY08/
A11; lane 3, bosR
2 OY08/F4; lane 4, bosR
2/+ OY33/A6; lane 5,
bosR
2/+ OY33/F7. RT-PCR (D) and immunoblot analyses (E)
were employed to determine the expression of BosR. a-BosR: rat
polyclonal antibody against BosR. Lanes and primer pair
designations are as in (C).
Found at: doi:10.1371/journal.ppat.1001272.s001 (9.61 MB TIF)
Figure S2 Characterization of the bosR mutants. (A) Plasmid
contents of Bb parental strain 297 (Bb297) and the bosR mutant
clone OY08/A11 via PCR amplification. Each plasmid for
detection is designated above each gel lane. DNA size standards
(M) are indicated at the left in base pairs. (B) In vitro growth of bosR
mutants. Bb was inoculated into BSK-II medium at 1000
spirochetes/ml and grown at 37uC. Spirochetes were enumerated
using dark-field microscopy. Values are the means from three
independent experiments. Error bars indicate standard deviations
(n = 3). Bb strain designations are: WT Bb297; bosR mutants
OY08/A11 and OY08/F4; complemented strains OY33/A6 and
OY33/F7.
Found at: doi:10.1371/journal.ppat.1001272.s002 (8.88 MB TIF)
Figure S3 3D structural analysis of the Bb BosR protein. The
3D model of BosR was generated using the Swiss-model server
(http://swissmodel.expasy.org/) based on the Vibrio Cholerae Fur
protein structure (Protein Data Bank: 2W57B) as a template. The
structure of PerR protein was derived from the active form of
PerR from Bacillus subtilis (Protein Data Bank: 3F8NA).
Found at: doi:10.1371/journal.ppat.1001272.s003 (7.75 MB TIF)
Table S1 Oligonucleotide primers used in this study.
Found at: doi:10.1371/journal.ppat.1001272.s004 (0.03 MB PDF)
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